
    
      This a multicenter, controlled, randomized, prospective, parallel, double-blinded study to
      evaluate the effect of an infant formula containing a new probiotic, Bifidobacterium longum
      biovar infantis CECT7210, on the incidence of diarrhea in healthy infants born at term.
      Infants will be randomized to take an standard infant formula or the infant formula with the
      probiotic CECT7210 during 12 weeks.
    
  